Booking Resort Co.,Ltd.
324A
Flier Inc.
323A
Next Generation Technology Group
319A
B-style Holdings
302A
Forcia
304A
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.